Community/Retail

A new law introduced by 46th district representative and pharmacist Fred H. Mills, Jr. (D, St. Martin's), BSPharm, will increase access to pharmacy services for Louisiana patients.

A ruling issued yesterday by the Departments of Health and Human Services (HHS), Labor, and the Treasury will provide free access to clinical preventive care for millions of Americans.

OTC products containing ibuprofen, such as Advil, are a reasonable choice when considering options for self-care of acute pain.

Research presented at the Endocrine Society's annual meeting in June revealed an association between bisphenol A (BPA) and Polycystic Ovarian Syndrome (PCOS).

A proposal by the US Postal Service to cut Saturday mail delivery has sharpened the divide between community pharmacies and pharmacy benefit managers.

This article will briefly discuss some of these issues, including treatment of diabetes (focusing on the initial treatment choices) and individualization of therapy and adherence, and will introduce an extended-release metformin dosage form, Glumetza.

Eighty percent of stroke risk can be boiled down to 5 simple, modifiable lifestyle factors, according to a large international study published in the Lancet.

A mass exodus of retirement-age, baby boomer generation nurses and physicians may create more opportunities for pharmacists to provide counseling and OTC recommendations.

Research presented at the Endocrine Society's annual meeting in San Diego, California, suggests vitamin D may play a more active role in diabetes development and control than previously thought.

A new law designed to reduce pharmaceutical waste could have unintended consequences for the 7000 community pharmacies that serve Medicare patients in long-term care facilities.

Can external oversight, in the form of a voluntary accreditation program, prevent the pharmacy industry's equivalent to the Gulf oil spill?

A variety of factors increase the risk of an individual developing Lyme Disease. This article reviews the disease, as well as current treatment and prevention options.

As the Iowa Board of Pharmacy negotiates with state lawmakers on the issue of medical marijuana, dispensaries and other business owners renew attempts to legitimize the drug's image.